Emerging Trends in Mass Tort Litigation: What to Watch in 2025
Mass tort litigation has long been a mechanism for holding corporations accountable, especially when their actions result in widespread harm. As 2025 unfolds, new developments are reshaping this dynamic field. Technological innovations, evolving legal strategies, and emerging areas of focus are redefining the landscape. This blog delves into key trends shaping mass tort litigation this year and their implications for plaintiffs, attorneys, and corporations.
Bayer’s Roundup: An Ongoing Battle
In 2020, Bayer attempted to close the chapter on lawsuits involving its weedkiller Roundup with a $10.9 billion settlement. However, litigation remains far from resolved. Over 50,000 claims persist, alleging that glyphosate, Roundup’s active ingredient, causes cancer.
Bayer, which acquired Roundup through its $63 billion purchase of Monsanto in 2018, maintains that glyphosate is safe. While the company has secured favorable verdicts in several recent trials, it has also faced massive judgments totaling over $1 billion, even after reductions on appeal. Bayer’s legal strategy hinges on the U.S. Supreme Court potentially ruling that federal law preempts plaintiffs’ claims. A circuit split earlier this year suggests Bayer might have an opportunity to make this case, although no petition to the high court has been filed yet.
As Roundup trials continue into 2025, their outcomes will be pivotal. Will Bayer achieve a decisive legal victory, or will it negotiate another substantial settlement? The stakes remain high, both for Bayer’s reputation and for consumers seeking justice.
Preterm Infant Formula Litigation
Litigation involving baby formula for premature infants has garnered significant attention. Claims allege that formulas produced by Abbott and Reckitt Benckiser’s Mead Johnson cause necrotizing enterocolitis (NEC), a deadly bowel disease. Recent verdicts include a $60 million judgment against Mead and a staggering $495 million award against Abbott. While the companies won the third and most recent trial, nearly 1,000 cases remain pending.
These lawsuits have raised alarms not only among investors but also within the medical community. Many doctors argue that the claims are based on flawed science and could jeopardize the availability of critical products for neonatal intensive care units. The manufacturers assert that while breast milk offers protective benefits, their formulas do not cause NEC.
The ongoing litigation in 2025 will be closely monitored, as its outcomes could significantly impact medical practices, corporate accountability, and the availability of life-saving products.
Spotlight on Weight Loss Drugs
A new class of weight loss medications, including Ozempic, Wegovy, and Mounjaro, dominated the headlines in 2024 and continues to be a focal point in 2025. These drugs have spurred multiple waves of litigation:
- Trademark and Competition Lawsuits: Novo Nordisk and Eli Lilly have aggressively pursued legal action against weight loss clinics and supplement companies for selling compounded weight loss drugs without FDA approval. They have also filed patent lawsuits to prevent generic versions of their drugs from entering the market.
- Product Liability Claims: Both companies face numerous lawsuits alleging that GLP-1 agonists, the active ingredients in these drugs, cause severe side effects, including gastroparesis. These cases have been consolidated as multidistrict litigation in Pennsylvania.
The litigation landscape surrounding GLP-1 agonists is expected to expand. These “miracle drugs” are being developed to treat conditions ranging from alcoholism and Alzheimer’s disease to asthma and cardiovascular issues. As their applications grow, so too will the scrutiny and potential legal challenges.
Environmental and Climate-Related Mass Torts
The surge in environmental awareness has fueled an uptick in litigation tied to pollution, toxic waste, and climate change. Communities affected by industrial negligence, such as contaminated water supplies or hazardous emissions, are increasingly turning to mass torts to seek justice.
- Noteworthy Cases: Litigation over PFAS, also known as “forever chemicals,” has gained traction due to their link to serious health issues. Companies producing these substances are facing mounting legal and financial pressure.
- Broader Implications: These cases are not just about compensation but also about forcing industries to adopt greener practices and improve transparency.
Technological Innovations in Case Management
Advancements in technology are transforming how mass tort cases are handled:
- AI and Machine Learning: Attorneys are leveraging AI for efficient legal research, data analysis, and case preparation. This technology helps process massive datasets quickly, uncovering critical evidence.
- Blockchain for Evidence: Blockchain technology is being used to securely document and verify evidence, ensuring its integrity throughout the litigation process.
- Virtual Proceedings: Virtual trials, depositions, and mediations—popularized during the pandemic—remain a cost-effective and time-saving tool in mass tort litigation.
These innovations not only enhance efficiency but also improve access to justice for plaintiffs.
Data Privacy and Cybersecurity Lawsuits
The rise of digital platforms has brought data privacy and cybersecurity to the forefront of legal disputes. Mass tort claims are increasingly targeting corporations for failing to protect consumer data, leading to identity theft and financial losses.
- Emerging Cases: Lawsuits against tech giants and healthcare providers dominate this space. Victims allege negligence in safeguarding sensitive information.
- Regulatory Impact: Compliance with data protection regulations, such as the GDPR and state-level laws in the U.S., will be a critical factor in these cases.
Bellwether Trials’ Growing Significance
Bellwether trials are becoming an essential strategy in mass tort litigation. These test cases provide insight into the strengths and weaknesses of claims, guiding settlement negotiations.
- New Developments: The use of advanced analytics to predict outcomes and refine trial strategies is on the rise.
- Broader Application: Bellwether trials are now being utilized in less traditional mass tort areas, such as data breaches and environmental claims.
Evolving Legal Theories
Attorneys are adopting innovative legal theories to tackle complex mass tort cases:
- Public Nuisance Claims: Initially used in opioid litigation, this theory is being applied to other industries, including technology and climate change.
- Third-Party Liability: Expanding accountability to include distributors, advertisers, and other entities in the supply chain.
These strategies aim to widen the net of accountability, ensuring that all responsible parties are held liable.
Implications for Stakeholders
- Plaintiffs: Awareness of emerging trends helps individuals recognize when they may have a valid claim and take timely action.
- Attorneys: Legal professionals must stay informed about technological advancements, regulatory changes, and innovative strategies to remain competitive.
- Corporations: Companies must prioritize compliance, transparency, and proactive risk management to mitigate potential liabilities.
Final Thoughts
Mass tort litigation in 2025 is set to be marked by complexity and innovation. From high-stakes environmental and pharmaceutical cases to groundbreaking technological tools, the field is evolving rapidly. Whether you are a plaintiff seeking justice or an attorney navigating this landscape, understanding these trends is essential.
At Connect2Attorney, we specialize in helping individuals navigate the intricacies of mass tort litigation. If you believe you have a claim, reach out to us today. Together, we can help ensure accountability and justice.
References –
